Literature DB >> 7906704

Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder.

M Nishimura1, J Toki, K Sugiura, F Hashimoto, T Tomita, H Fujishima, Y Hiramatsu, N Nishioka, N Nagata, Y Takahashi.   

Abstract

The etiopathogenesis of focal and segmental glomerular sclerosis (FGS) remains unknown. Using a new animal model for FGS (FGS mouse), we demonstrate here that bone marrow transplantation from normal mice to FGS mice with a high grade of proteinuria (+ + +) ameliorates FGS, and that the transplantation of bone marrow cells or purified hemopoietic stem cells (HSCs) from FGS mice induces FGS in normal mice. These findings strongly suggest that FGS is a stem cell disorder; the abnormalities may be genetically programmed at the level of HSCs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7906704      PMCID: PMC2191400          DOI: 10.1084/jem.179.3.1053

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Focal sclerosing glomerulonephropathy with segmental hyalinosis. A clinicopathologic analysis.

Authors:  L R Hyman; P M Burkholder
Journal:  Lab Invest       Date:  1973-05       Impact factor: 5.662

2.  Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/KN mice by transplantation of bone marrow cells plus bone (stromal cells).

Authors:  T Nakagawa; N Nagata; N Hosaka; R Ogawa; K Nakamura; S Ikehara
Journal:  Arthritis Rheum       Date:  1993-02

3.  Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis.

Authors:  R J Glasser; J A Velosa; A F Michael
Journal:  Lab Invest       Date:  1977-05       Impact factor: 5.662

4.  Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

Authors:  T K Rao; E J Filippone; A D Nicastri; S H Landesman; E Frank; C K Chen; E A Friedman
Journal:  N Engl J Med       Date:  1984-03-15       Impact factor: 91.245

5.  Focal and segmental glomerulosclerosis and porteinuria associated with unilateral renal agenesis.

Authors:  D D Kiprov; R B Colvin; R T McCluskey
Journal:  Lab Invest       Date:  1982-03       Impact factor: 5.662

6.  Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation.

Authors:  S Ikehara; H Ohtsuki; R A Good; H Asamoto; T Nakamura; K Sekita; E Muso; Y Tochino; T Ida; H Kuzuya
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

7.  Renal disease in patients with AIDS: a clinicopathologic study.

Authors:  M H Gardenswartz; C W Lerner; G R Seligson; P M Zabetakis; H Rotterdam; M L Tapper; M F Michelis; M S Bruno
Journal:  Clin Nephrol       Date:  1984-04       Impact factor: 0.975

8.  Spontaneous nephrotic syndrome in a genetic rat model.

Authors:  C R Abramowsky; M Aikawa; G L Swinehart; R M Snajdar
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

9.  Focal glomerular sclerosis in aminonucleoside nephropathy.

Authors:  T Saito; T Furuyama; Y Kyogoku; K Yamakage; M Arakawa; K Yoshinaga
Journal:  Tohoku J Exp Med       Date:  1981-03       Impact factor: 1.848

10.  Rationale for bone marrow transplantation in the treatment of autoimmune diseases.

Authors:  S Ikehara; R A Good; T Nakamura; K Sekita; S Inoue; M M Oo; E Muso; K Ogawa; Y Hamashima
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

View more
  10 in total

1.  Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.

Authors:  N Hosaka; T Ryu; T Miyake; W Cui; T Nishida; T Takaki; M Inaba; S Ikehara
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

2.  Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats.

Authors:  Ludmilla Le Berre; Yann Godfrin; Eberhard Günther; Françoise Buzelin; Sabine Perretto; Helga Smit; Dontscho Kerjaschki; Claire Usal; Cristina Cuturi; Jean-Paul Soulillou; Jacques Dantal
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 3.  Extrarenal determinants of kidney filter function.

Authors:  Eunsil Hahm; Vasil Peev; Jochen Reiser
Journal:  Cell Tissue Res       Date:  2017-05-30       Impact factor: 5.249

4.  Stem cell mobilization in idiopathic steroid-sensitive nephrotic syndrome.

Authors:  Hélène Lapillonne; Annelaure Leclerc; Tim Ulinski; Laurent Balu; Arnaud Garnier; Nathalie Dereuddre-Bosquet; Hervé Watier; Marie-Hélène Schlageter; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2008-05-06       Impact factor: 3.714

Review 5.  The future of stem cell transplantation in autoimmune disease.

Authors:  Susumu Ikehara
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

6.  What is the significance of CD34 immunostaining in the extraglomerular and intraglomerular mesangium?

Authors:  Cristina Gluhovschi; Gheorghe Gluhovschi; Elena Potencz; Diana Herman; Ligia Petrica; Silvia Velciov; Gheorghe Bozdog; Flaviu Bob; Corina Vernic; Daniel Cioca
Journal:  Virchows Arch       Date:  2008-08-08       Impact factor: 4.064

Review 7.  Monoclonal antibodies for podocytopathies: rationale and clinical responses.

Authors:  Maddalena Marasà; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314

Review 8.  Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models.

Authors:  Sylvana M L de Mik; Martin J Hoogduijn; Ron W de Bruin; Frank J M F Dor
Journal:  BMC Nephrol       Date:  2013-04-01       Impact factor: 2.388

Review 9.  Intractable diseases treated with intra-bone marrow-bone marrow transplantation.

Authors:  Ming Li; Kuquan Guo; Susumu Ikehara
Journal:  Front Cell Dev Biol       Date:  2014-09-02

Review 10.  Stem/progenitor cell in kidney: characteristics, homing, coordination, and maintenance.

Authors:  Jiewu Huang; Yaozhong Kong; Chao Xie; Lili Zhou
Journal:  Stem Cell Res Ther       Date:  2021-03-20       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.